A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/23/1997	US5700837 Method and composition for normalizing injury response
12/23/1997	US5700836 Topically administering to treat photodamaged skin
12/23/1997	US5700835 3-Oxa-D-prostaglandins for lowering IOP
12/23/1997	US5700832 Antianemic agent containing iron and difructose
12/23/1997	US5700830 Prevention adhesion of cancerous cells and noncancerous structures in mammals
12/23/1997	US5700828 Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions
12/23/1997	US5700825 Used to kill hypoxic tumor cells
12/23/1997	US5700823 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide or n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide
12/23/1997	US5700822 Treatment of platelet derived growth factor related disorders such as cancers
12/23/1997	US5700821 Inhibit cell proliferation
12/23/1997	US5700818 Serotonin antagonists for treatment of nervous system, brain or psychological disorders
12/23/1997	US5700816 Antiarthritic agents
12/23/1997	US5700815 Methods of increasing thrombomodulin expression
12/23/1997	US5700814 Active material, carrier, ph in range 8 to 10; alzheimer's disease
12/23/1997	US5700813 Treatment of thrombotic illness
12/23/1997	US5700812 Antispasmodic agent for cardiovascular disorder, antiserotonine agent
12/23/1997	US5700811 Potent inducers of terminal differentiation and method of use thereof
12/23/1997	US5700808 5- or 6-substituted β-carboline-3-carboxylic acid esters
12/23/1997	US5700807 Endothelin receptor antagonists
12/23/1997	US5700806 Farnesyl protein transferase enzyme inhibitor, antitumor agents
12/23/1997	US5700804 Inhibitors of plasminogen activator inhibitors
12/23/1997	US5700803 Method for reducing infarct size in subjects afflicted with ischemic heart disease
12/23/1997	US5700801 Antiinflammatory agents, bone disorders
12/23/1997	US5700800 Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
12/23/1997	US5700799 Oxazolidinone antimicrobials containing substituted diazine moieties
12/23/1997	US5700798 Methods for using benzoxazines for treating asthma
12/23/1997	US5700797 N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
12/23/1997	US5700796 Useful for treating congestive heart failure, disease conditions with excess renal water reabsorption and conditions with increased vasular resistance and coronary vasoconstriction
12/23/1997	US5700795 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of type II diabetes
12/23/1997	US5700794 Treatment of ocular hypotony
12/23/1997	US5700791 Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof
12/23/1997	US5700790 Prevention and treatment of myocardial failure
12/23/1997	US5700789 Antiallergic composition comprising a phosphoric diester compound
12/23/1997	US5700788 Treatment of hiv
12/23/1997	US5700787 Capsular polysaccharide immunomodulator
12/23/1997	US5700784 Glycosides of hydroxysalicylic acid and/or glycosides of esters of hydroxysalicylic acid; excellent whitening effect and skin care effect
12/23/1997	US5700774 Treatment of bone disorders
12/23/1997	US5700675 Protein kinase required for Ras signal transduction
12/23/1997	US5700640 Stimulate cell differentiation
12/23/1997	US5700590 Infant formula; specified weight ratios of nucleotide equivalents
12/23/1997	US5700486 Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions
12/23/1997	US5700485 Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
12/23/1997	US5700484 Sustained release microparticulate caffeine formulation
12/23/1997	US5700483 Retinoic acid-containing compositions
12/23/1997	US5700480 Having impermeable backing layer, pressure sensitive adhesive reservoir layer comprising polyacrylate, plasticizer, galanthamine base or salt
12/23/1997	US5700468 Extracts of ginkgo biloba and their methods of preparation
12/23/1997	US5700458 Acid-functionalized saccharides as polyvalent anti-infectives
12/23/1997	US5700450 Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof
12/23/1997	US5700447 Methods and materials for the diagnosis and treatment of conditions such as stroke
12/23/1997	US5700396 Cosmetic compositions and an emulsion composition
12/23/1997	CA2178637C Paroxetine tablets and process to prepare them
12/23/1997	CA2126972C Styrene derivative and salts thereof
12/23/1997	CA2103324C N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
12/23/1997	CA2076430C Pyrrolidylthiocarbapenem derivative
12/23/1997	CA2052901C Pharmacologically enhanced formulations
12/23/1997	CA2025855C Pharmaceutical compositions having activity on the cutaneous microcirculation
12/23/1997	CA2012791C Spray gel base and spray gel preparation
12/23/1997	CA2008391C 1,2-cyclohexylaminoaryl amides useful as analgesic agents
12/23/1997	CA1339599C Epoxide derivatives
12/20/1997	CA2208998A1 Uronic glycoside fluoroalkyl acids and associated lactones-6(3), prepar ation and uses therefor
12/20/1997	CA2208174A1 Squalene synthetase inhibitors
12/19/1997	CA2208136A1 Inhibition of abnormal accumulation of extracellular matrices
12/18/1997	WO1997047659A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
12/18/1997	WO1997047644A1 T cell antigen receptor peptides
12/18/1997	WO1997047638A1 Cellular injury response element and uses thereof
12/18/1997	WO1997047637A1 Phosphotriester oligonucleotides, amidites and method of preparation
12/18/1997	WO1997047634A1 Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
12/18/1997	WO1997047623A1 Imidazole derivatives as protective agents in reperfusion injury and severe inflammatory responses
12/18/1997	WO1997047619A1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
12/18/1997	WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity
12/18/1997	WO1997047616A1 6,7-dihydroxy-8-methyl-4-oxo-4h-1-benzopyran-5-carboxylic acid with antibacterial activity
12/18/1997	WO1997047612A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same
12/18/1997	WO1997047611A1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents
12/18/1997	WO1997047604A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
12/18/1997	WO1997047603A1 New compounds
12/18/1997	WO1997047602A1 Tricyclic amine derivatives
12/18/1997	WO1997047599A1 Succinamide derivatives useful as tnf- and/or mmp inhibitors
12/18/1997	WO1997047595A1 Endothelin antagonist
12/18/1997	WO1997047593A2 Peptides
12/18/1997	WO1997047584A1 Polyol succinates and their pharmaceutical formulation
12/18/1997	WO1997047577A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them
12/18/1997	WO1997047358A1 Synthetic hepatitis c genes
12/18/1997	WO1997047333A1 Novel devices for transdermal administering of trimegestone
12/18/1997	WO1997047327A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
12/18/1997	WO1997047324A1 Method of using aloe vera as a biological vehicle
12/18/1997	WO1997047315A1 Method of stimulating cilia
12/18/1997	WO1997047312A1 Novel heparin binding peptides
12/18/1997	WO1997047310A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
12/18/1997	WO1997047308A1 Eutrophic drug compositions based on transferrin glycans
12/18/1997	WO1997047307A1 Use of histone deacetylase inhibitors to activate transgene expression
12/18/1997	WO1997047305A1 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
12/18/1997	WO1997047304A1 Fast-dissolving galanthamine hydrobromide tablet
12/18/1997	WO1997047303A1 Substituted benzylidene indenyl formamides, acetamides and propionamides
12/18/1997	WO1997047302A1 Inhibition of serotonin reuptake
12/18/1997	WO1997047301A1 Improved process for preparing potassium clavulanate
12/18/1997	WO1997047300A1 Antimycotics with metronidazole for treatment of skin disorders
12/18/1997	WO1997047298A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	WO1997047297A1 Antirheumatic agent
12/18/1997	WO1997047296A2 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
12/18/1997	WO1997047295A1 Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions

1 ... 6710 6711 6712 6713 6714 6715 6716 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 ... 7860